Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-04-01 · accession 0001209191-22-022540 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-04-04 | 2022-04-01 | JBIO | Atlas Venture Fund XII, L.P. | 10% | J - Other | $0.00 | -465.6K | 2.64M | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | J | D | 465,582 | $0.00 | 2,638,297 | D | — | — |